TWD 42.0
(6.06%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -196.52 Million TWD | 81.25% |
2022 | -1.04 Billion TWD | -98.82% |
2021 | -527.12 Million TWD | -83473.96% |
2020 | -630.72 Thousand TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -1.57 Billion TWD | 0.74% |
2024 Q1 | -1.57 Billion TWD | -702.03% |
2023 Q4 | -196.52 Million TWD | 5.6% |
2023 FY | -196.52 Million TWD | 81.25% |
2023 Q3 | -208.18 Million TWD | 50.87% |
2023 Q2 | -423.75 Million TWD | 2.2% |
2023 Q1 | -433.29 Million TWD | 58.65% |
2022 Q4 | -1.04 Billion TWD | -0.0% |
2022 Q3 | -1.04 Billion TWD | 0.0% |
2022 FY | -1.04 Billion TWD | -98.82% |
2021 FY | -527.12 Million TWD | -83473.96% |
2020 FY | -630.72 Thousand TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 25.605% |
Level Biotechnology Inc. | -453.9 Million TWD | 56.703% |
Sagittarius Life Science Corp | -120.57 Million TWD | -62.999% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -0.067% |
TaiMed Biologics Inc. | 499.84 Million TWD | 139.318% |
GlycoNex Incorporation | -148.56 Million TWD | -32.282% |
VBI | -25.31 Million TWD | -676.3% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 588.074% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 242.417% |
Visgeneer Inc. | 31.28 Million TWD | 728.206% |
Mycenax Biotech Inc. | 207 Million TWD | 194.937% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 71.125% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -46.387% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 131.62% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -240.851% |
Enimmune corporation | -314.15 Million TWD | 37.443% |
TaiRx, Inc. | -147.86 Million TWD | -32.907% |
CHO Pharma, Inc. | -203.79 Million TWD | 3.564% |
EirGenix Inc. | -4.58 Billion TWD | 95.716% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -131.856% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 262.593% |
Lin BioScience, Inc. | -3.21 Billion TWD | 93.893% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 38.085% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -891.914% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 717.838% |
Lukas Biomedical Inc. | 50.75 Million TWD | 487.209% |
RBC Bioscience Corporation | 422.18 Million TWD | 146.55% |
BiOptic Inc. | 12.59 Million TWD | 1660.737% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 79.19% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -93.65% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -18.981% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 162.415% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -155.085% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 25.156% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 742.71% |
Neith Corporation | -150.31 Million TWD | -30.748% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -205.543% |
NaviFUS Corp. | -123.12 Million TWD | -59.611% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 365.395% |
Sinew Pharma Inc. | -160.34 Million TWD | -22.566% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 18.754% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 41.748% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 52.373% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 128.535% |
3D Global Biotech Inc. | -11.43 Million TWD | -1618.353% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 76.313% |
Intech Biopharm Corporation | 1.35 Billion TWD | 114.479% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 52.63% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 6.119% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -36.608% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 40.544% |
TCI GENE Inc. | -689.25 Million TWD | 71.487% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -65.236% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 84.989% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1059.469% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -92.92% |
PharmaEngine, Inc. | -860.8 Million TWD | 77.169% |
Savior Lifetec Corporation | -812.54 Million TWD | 75.813% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 34.484% |
OBI Pharma, Inc. | -398.22 Million TWD | 50.649% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 46.218% |
Acepodia, Inc. | -6.02 Billion TWD | 96.736% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 94.223% |